Analysts expect Global Medical REIT Inc (NYSE:GMRE) to post $0.20 earnings per share (EPS) for the current quarter, according to Zacks. Five analysts have issued estimates for Global Medical REIT’s earnings, with the lowest EPS estimate coming in at $0.18 and the highest estimate coming in at $0.24. Global Medical REIT also reported earnings of $0.20 per share during the same quarter last year. The firm is expected to report its next quarterly earnings results on Tuesday, August 6th.

According to Zacks, analysts expect that Global Medical REIT will report full-year earnings of $0.78 per share for the current year, with EPS estimates ranging from $0.75 to $0.85. For the next financial year, analysts expect that the company will report earnings of $0.85 per share, with EPS estimates ranging from $0.77 to $0.94. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last posted its earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.20 by ($0.18). Global Medical REIT had a return on equity of 5.52% and a net margin of 21.38%. The firm had revenue of $15.20 million for the quarter, compared to analyst estimates of $15.32 million.

A number of equities research analysts have issued reports on GMRE shares. Zacks Investment Research raised Global Medical REIT from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a research report on Wednesday, February 13th. Boenning Scattergood reaffirmed a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th. B. Riley set a $11.00 price target on Global Medical REIT and gave the company a “buy” rating in a research report on Friday, March 8th. Stifel Nicolaus started coverage on Global Medical REIT in a research report on Monday, April 15th. They issued a “buy” rating and a $11.00 price target on the stock. Finally, TheStreet raised Global Medical REIT from a “c+” rating to a “b” rating in a research report on Thursday, May 9th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $10.67.

In other Global Medical REIT news, Director Roscoe M. Moore, Jr. sold 5,945 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $9.75, for a total value of $57,963.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. 11.70% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of the business. Financial Advantage Inc. purchased a new position in shares of Global Medical REIT in the 1st quarter valued at about $31,000. Daiwa Securities Group Inc. increased its holdings in shares of Global Medical REIT by 100.0% in the 1st quarter. Daiwa Securities Group Inc. now owns 3,800 shares of the company’s stock valued at $37,000 after acquiring an additional 1,900 shares during the last quarter. BNP Paribas Arbitrage SA increased its holdings in shares of Global Medical REIT by 639.1% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,782 shares of the company’s stock valued at $47,000 after acquiring an additional 4,135 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. increased its holdings in shares of Global Medical REIT by 71.0% in the 1st quarter. Ladenburg Thalmann Financial Services Inc. now owns 6,500 shares of the company’s stock valued at $63,000 after acquiring an additional 2,699 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its holdings in shares of Global Medical REIT by 19.9% in the 1st quarter. State of Alaska Department of Revenue now owns 7,412 shares of the company’s stock valued at $72,000 after acquiring an additional 1,229 shares during the last quarter. 47.77% of the stock is currently owned by institutional investors.

GMRE opened at $10.80 on Friday. Global Medical REIT has a 12-month low of $8.10 and a 12-month high of $11.11. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.76. The stock has a market cap of $363.08 million, a P/E ratio of 13.85, a PEG ratio of 1.55 and a beta of 0.61.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Article: Why are trading ranges significant?

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.